Top 20 Amplyx Pharmaceuticals investors
The most complete profiles first. Showing 20 of 20.
Alex KahnVerified
Venture Capital, Angel/Individual · United States
SeedPre-SeedHealth CareEnterprise SoftwareArtificial Intelligence (AI)AnalyticsPortfolio: Nuve, Inspire, Inspire Energy, Promethium and 14 more
Verified email available
Jonathan LeffVerified
Venture Capital, Investor · United States
SeedSeries BHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more
Verified email available
Sarah BhagatVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Alan ColowickVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Jason PittsVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Mike PowellVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Derek Rapp
Venture Capital, Private Equity Firm, Investor · United States
SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife SciencePortfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more
Contact details available
Isaac Zike Ph.D.
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more
Contact details available
Jay Schmelter
Venture Capital, Founder, Private Equity Firm · United States
SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife SciencePortfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more
Contact details available
John McKearn
Venture Capital, Private Equity Firm, Investor · United States
SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife SciencePortfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more
Contact details available
Karen Spilizewski
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more
Contact details available
Maha Katabi, PhD, CFA
Hedge Fund, Venture Capital, Investor · Canada
SeedHealth CareGeneticsWomen FoundedInvestment ManagementPortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more
Contact details available
Nancy Hong, PhD
Venture Capital, Investor · United States
SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife SciencePortfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 37 more
Contact details available
Perry Nisen
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Tom Melzer
Venture Capital, Founder, Investor · United States
Series BSeries AHealth CareWomen FoundedEnterprise SoftwareLife SciencePortfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more
Contact details available
Alfred Yue
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Cookie Yu
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Amplyx Pharmaceuticals, Mirum Pharmaceuticals, OrphoMed, Allievex and 9 more
Contact details available
Ford Worthy
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Amplyx Pharmaceuticals, Mirum Pharmaceuticals, OrphoMed, Allievex and 9 more
Contact details available
Hooman Shahlavi
Hedge Fund, Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Tom Mathers
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Amplyx Pharmaceuticals, Mirum Pharmaceuticals, OrphoMed, Allievex and 9 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Amplyx Pharmaceuticals investors are on Angel Roster?
Angel Roster lists 20 Amplyx Pharmaceuticals investors. 6 of them (30%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (20), Private Equity Firms (5) and Hedge Funds (2). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Amplyx Pharmaceuticals investors invest in?
Among those that list a stage, the most common are Seed (11), Pre-Seed (5) and Series B (2).
Where are Amplyx Pharmaceuticals investors based?
Most are based in the United States (19) and Canada (1).
Which companies have Amplyx Pharmaceuticals investors backed?
The most-backed portfolio companies among them are ZS Pharma (16), VelosBio (12), Mirum Pharmaceuticals (10), Reneo Pharmaceuticals (10) and Coherus Biosciences (9).
How do I contact Amplyx Pharmaceuticals investors?
Create a free Angel Roster account to search and filter all 20, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.